Defense Health Agency Contracting Activity - DHACA

Description

The GBMRP recognizes the critical need for improved outcomes for individuals with glioblastoma. The GBMRP FY24 Transformative Consortium Award (TCA) is designed to support a multidisciplinary collaborative effort of at least four, but not more than five, distinct yet complementary projects that collectively address a central hypothesis. Applications for the TCA may propose clinical or translational research projects and/or clinical trials and must address at least one of the FY24 GBMRP Areas of Emphasis. This award requires a team-based approach by a consortium of exceptional researchers and at least one consumer advocate, whose collaborative efforts will catalyze scientific discovery, drive innovation, and make breakthroughs that could not be accomplished by a single investigator or group.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org